Premier Alternatives

Enquyst Technologies

North Brunswick, NJ · Founded 2017 · Privately Held (backing)

Developer of biomanufacturing process technologies designed to reduce production costs and improve scalability for biologics. Enquyst Technologies is based in North Brunswick, NJ and was founded in 2017. Its last reported valuation was $107 million in May 2025. It has raised $11.2 million.

Last reported valuation
$107.0M
Oct 2026
Priced at
—
Total raised
$11.2M
Last round
—

Enquyst Technologies key facts

as of Oct 2026
  • Developer of biomanufacturing process technologies designed to reduce production costs and improve scalability for biologics.
  • Enquyst Technologies is valued at approximately $107.0M as of Oct 2026 (last reported valuation).
  • It has raised $11.2M; the latest was Later Stage VC ($6.0M) in May 2025.
  • Notable investors include New Jersey Economic Development Authority, Eckuity, Capnor (Germany), Forepont Capital Partners, Innovation and Technology — 6 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$107.0M

Enquyst Technologies's last reported valuation, May 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Enquyst Technologies with a free account
  • ·Watch Enquyst Technologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Enquyst Technologies funding rounds

No rounds on record

No funding rounds for Enquyst Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Enquyst Technologies valuation

Enquyst Technologies's last reported valuation was $107 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.

Enquyst Technologies investors

6 investors are on record for Enquyst Technologies, including New Jersey Economic Development Authority, Eckuity, Capnor (Germany) and Forepont Capital Partners.

About Enquyst Technologies

Developer of biomanufacturing process technologies designed to reduce production costs and improve scalability for biologics. The company offers a modular, chromatography-free, and continuous manufacturing system that supports monoclonal antibody production and viral vector separation, enabling biopharmaceutical companies and contract development organizations to streamline downstream processing, minimize capital and operating expenditures, and accelerate access to high-purity biologic therapies.

Sector
Healthcare
HQ
North Brunswick, NJ, United States
Founded
2017
Employees
10
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.